Roscovitine

A purine derivative and competitive inhibitor of CYCLIN-DEPENDENT KINASES that has therapeutic potential as an antineoplastic and antiviral agent.

Year introduced: 2019 (1997)

PubMed search builder options

Subheadings:

Restrict to MeSH Major Topic.

Do not include MeSH terms found below this term in the MeSH hierarchy.

Tree Number(s): D03.633.100.759.776

MeSH Unique ID: D000077546

Registry Number: 0ES1C2KQ94

Entry Terms:

• (2R)-2-((6-Benzylamino-9-(propan-2-yl)-9H-purin-2-yl)amino)butan-1-ol
• CYC 202
• CYC-202
• CYC202
• R-roscovitine
• R roscovitine
• Seliciclib
• 2-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine

Pharmacologic Action:

• Antineoplastic Agents
• Antiviral Agents
• Protein Kinase Inhibitors

All MeSH Categories
Chemicals and Drugs Category
Heterocyclic Compounds
Heterocyclic Compounds, Fused-Ring
Heterocyclic Compounds, 2-Ring
Purines
Roscovitine